Journal article
Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital
Abstract
BACKGROUND: Patients who continue to smoke after acute coronary syndrome are at increased risk of reinfarction and death. We previously found use of varenicline to increase abstinence 24 weeks after acute coronary syndrome; here we report results through 52 weeks.
METHODS: The EVITA trial was a multicentre, double-blind, randomized, placebo-controlled trial of varenicline for smoking cessation in patients admitted to hospital with acute …
Authors
Windle SB; Dehghani P; Roy N; Old W; Grondin FR; Bata I; Iskander A; Lauzon C; Srivastava N; Clarke A
Journal
Canadian Medical Association Journal, Vol. 190, No. 12, pp. e347–e354
Publisher
Joule
Publication Date
March 26, 2018
DOI
10.1503/cmaj.170377
ISSN
0820-3946